Trial Profile
A Phase IIa Clincal Trial Treating Patients With Early Stage Breast Cancer for Not Exceding 7 Days Prior Surgery With PTS(para-toluenesulfonamide injection), A Novel Local Invasive Anticancer Drug, Administered By Local and Intratumoral Injection Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs P-toluenesulfonamide (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors Beijing Vision Drugs Development
- 21 Aug 2015 New trial record